(PharmaNewsWire.Com, August 30, 2017 ) According to the report, Asia Pacific Cancer Monoclonal Antibodies Market published by the Market Data Forecast. The market is currently valued at USD 4.32 billion in 2015 and is forecasted to be a USD 8.14 Billion market by 2020 with a tremendous growth rate of 13.5%.
Cancer is the leading cause of death across the globe currently. It starts from a single cell in the body genetically transforming a normal cell to a tumour and is eventually spread to other cells. Typically, drugs and chemotherapy are used as a treatment to cure cancer. The adverse side effects that comes with them has made the pharmaceutical companies to concentrate on monoclonal antibodies.
Monoclonal antibodies have the ability to offer less toxic and more efficient therapeutic alternatives to treat the disease. Recent years have seen the emergence of monoclonal antibodies being used to treat wide array of diseases that are related to cancer. These antibodies are mono-specific comprising of identical immune cells which are clones of a single parent cell and are directed towards a specific cellular target. Thus monoclonal antibodies due to its customizable nature can be used to treat the cancerous cells not effecting the normal ones.
With the increase in the cases of cancer in the recent past, the pharmaceutical companies has started investing aggressively in monoclonal antibodies. The primary drivers for the market include increased investment in R&D for genomic studies, specificity to target only the cancer cell by monoclonal antibodies and technological evolvement in genetic sequencing and target gene selection. However, high costs of development, longer durations required for clinical trials and research & development of antibodies are a few factors to overcome in order for the market to evolve.
Asia Pacific Cancer Monoclonal Antibodies Market : Segmentation
• By Application o Liver o Breast o Brain o Blood o Hodgkins and Non-Hodgkins lymphoma o Colorectal o Leukaemia o Others
• By Type Murine Antibodies Chimeric and Humanised Antibodies Fully Humanized Antibodies o Conjugate Cancer Therapies Immunoliposome Radioimmunotherapy ADEPT Immunocytokines Others
Reasons to buy Asia Pacific Cancer Monoclonal Antibodies Market Report:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
